by div write | May 1, 2025 | Downgrades
Redburn Atlantic has downgraded Procter & Gamble from Buy to Neutral, assigning a revised price target of $161. This shift reflects concerns around the company’s limited room for upward movement and ongoing pressure on operating margins, despite its strong brand...
by div write | Apr 30, 2025 | Downgrades
Goldman Sachs has recently downgraded Starbucks Corporation (NASDAQ: SBUX) from “Buy” to “Neutral,” adjusting its price target to $85. The downgrade reflects mounting concerns about the company’s weakening growth trajectory and a valuation that...
by div write | Apr 30, 2025 | Downgrades
Wells Fargo recently shifted its rating on Gap Inc. (NYSE: GPS) from “Overweight” to “Equal Weight” with a revised price target of $24. The move signals growing concern over the company’s ability to maintain momentum amid brand inconsistencies...
by div write | Apr 29, 2025 | Downgrades
ConocoPhillips (NYSE: COP) has been downgraded by BofA Securities from Buy to Neutral. The move reflects growing caution around the short-term outlook for crude oil prices, which could weigh heavily on the company’s earnings growth. Despite strong operational...
by div write | Apr 29, 2025 | Downgrades
UBS has shifted its rating on National Grid (NYSE: NGG) from Buy to Neutral, signaling a cooling of optimism around the company’s near-term growth potential. National Grid has long been a staple for conservative, income-seeking investors, but UBS analysts cited...
by div write | Apr 28, 2025 | Downgrades
Eli Lilly (NYSE: LLY) has long been the darling of the pharmaceutical sector, riding the high of groundbreaking treatments and blockbuster sales. However, HSBC Securities recently turned heads by downgrading the stock from Buy to Reduce, slashing their price target...
